KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-9.54 Cr | ₹7.92 Cr | ₹-15 Cr | ₹-38 Cr | ₹-10 Cr |
What is the latest Cash Flow from Investing Activities ratio of KILITCH DRUGS (INDIA) ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-9.54 Cr |
Mar2023 | ₹7.92 Cr |
Mar2022 | ₹-15 Cr |
Mar2021 | ₹-38 Cr |
Mar2020 | ₹-10 Cr |
How is Cash Flow from Investing Activities of KILITCH DRUGS (INDIA) Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-9.54 Cr | Negative | |
Mar2023 | ₹7.92 Cr | Positive | |
Mar2022 | ₹-15 Cr | Negative | |
Mar2021 | ₹-38 Cr | Negative | |
Mar2020 | ₹-10 Cr | - |
Compare Cash Flow from Investing Activities of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹543.1 Cr | 3.7% | 11.5% | -6.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | 2.3% | 11.7% | 5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -1.6% | 4% | 58.7% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | 0.8% | 6.2% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 0.7% | 9.8% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -1% | 2.8% | -8% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 3.7% |
11.5% |
-6.7% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses